MedPath
NMPA Approval

Levocetirizine Dihydrochloride Oral Solution

国药准字H20253352

February 8, 2025

Drug Information

盐酸左西替利嗪口服溶液

口服溶液剂

150ml:75mg

化学药品

February 8, 2025

Company Information

Applicant Company

重庆市合川区南津街街道办事处荣军路666号

Manufacturing Company

湖南省岳阳经济技术开发区康王工业园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸左西替利嗪口服溶液 - NMPA 批准文号 | MedPath